Screen LibraryThomas' hematopoietic cell transplantation stem cell transplantation /
Saved in:
| Corporate Authors: | |
|---|---|
| Group Author: | ; |
| Published: |
|
| Literature type: | Electronic eBook |
| Language: | English |
| Edition: | 4th ed. |
| Subjects: | |
| Online Access: |
http://onlinelibrary.wiley.com/book/10.1002/9781444303537 |
| Carrier Form: | 1 online resource (xxx, 1718 p.) : ill. (some col.), ports. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9781444303537 1444303538 9781405153485 1405153482 |
| Index Number: | RD123 |
| CLC: | R457.1 |
| Contents: |
A history of allogeneic hematopoietic cell transplantation -- The history of autologous hematopoietic cell transplantation -- Uses and growth of hematopoietic cell transplantation -- Generation of definitive engraftable hematopoietic stem cells from human embryonic stem cells -- Biology of hematopoietic stem and progenitor cells -- Molecular biology of stem cell renewal -- Cellular biology of hematopoiesis -- Expansion of hematopoietic stem cells -- Mesenchymal stromal cells and hematopoietic cell transplantation -- Genetic manipulation of hematopoietic stem cells -- Overview of hematopoietic cell transplantation immunology -- Histocompatibility -- Natural killer cells and allogeneic hematopoietic cell transplantation -- Murine models of graft-versus-host disease and graft-versus-tumor effect -- Mechanisms of tolerance -- The pathophysiology of graft-versus-host disease -- Immune reconstitution following hematopoietic cell transplantation -- The human graft-versus-tumor response -- and how to exploit it -- Dendritic cells in hematopoietic cell transplantation -- The experimental basis for hematopoietic cell transplantation for autoimmune diseases -- Pharmacologic basis for high-dose chemotherapy -- High-dose preparatory regimens -- Radiotherapeutic principles of hematopoietic cell transplantation -- Radioimmunotherapy and hematopoietic cell transplantation -- Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation -- The detection and significance of minimal residual disease -- Pathology of hematopoietic cell transplantation -- Biostatistical methods in hematopoietic cell transplantation -- Outcomes research in hematopoietic cell transplantation -- The evaluation and counseling of candidates for hematopoietic cell transplantation -- Nursing role in hematopoietic cell transplantation -- Ethical issues in hematopoietic cell transplantation -- Psychosocial issues in hematopoietic cell transplantation -- Assessment of quality of life in hematopoietic cell transplantation recipients -- Sexuality following hematopoietic cell transplantation: an important health-related quality of life issue -- Hematopoietic cell transplantation: the patient's perspective. Hematopoietic cell procurement, processing, and transplantation: standards, accreditation, and regulation -- Bone marrow and peripheral blood cell donors and donor registries -- Cord blood hematopoietic cell transplantation -- In utero transplantation -- Mobilization of autologous peripheral blood hematopoietic cells for cellular therapy -- Removal of tumor cells from the hematopoietic graft -- Peripheral blood hematopoietic cells for allogeneic transplantation -- Cryopreservation of hematopoietic cells -- Use of recombinant growth factors after hematopoietic cell transplantation -- Hematopoietic cell transplantation from human leukocyte antigen partially matched related donors -- Hematopoietic cell transplantation from unrelated donors -- Donor selection for hematopoietic cell transplantation -- Hematopoietic cell transplantation for aplastic anemia -- Hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria -- Allogeneic and autologous transplantation for chronic myeloid leukemia -- Hematopoietic cell transplantation for juvenile myelomonocytic leukemia -- Hematopoietic cell transplantation for adult acute myeloid leukemia -- Hematopoietic cell transplantation for childhood acute myeloide leukemia -- Hematopoietic cell transplantation for acute lymphoblastic leukemia in adults -- Hematopoietic cell transplantation for acute lymphoblastic in children -- Hematopoietic cell transplantation for myelodysplastic syndrome and myeloproliferative disorders -- Hematopoietic cell transplantation for multiple myeloma -- Hematopoietic cell transplantation for Hodgkin's Disease -- Non-Hodgkin's lymphoma -- Hematopoietic cell transplantation for chronic lymphocytic leukemia -- Autologous hematopoietic cell transplantation for systemic light chain (AL- ) amyloidosis -- Hematopoietic cell transplantation for breast cancer -- Hematopoietic cell transplantation in germ cell tumors -- Hematopoietic cell transplantation for renal cell and other solid tumors -- Hematopoietic cell transplantation for neuroblastoma -- Hematopoietic cell transplantation for other pediatric solid tumors -- Hematopoietic cell transplantation for patients with human immunodeficiency virus infection -- Hematopoietic cell transplantation for autoimmune diseases -- Hematopoietic cell transplantation for rare hematologic malignancies -- Reduced-intensity conditioning followed by hematopoietic cell transplantation for hematologic malignancies -- Management of relapse after hematopoietic cell transplantation. Hematopoietic cell transplantation for thalassemia -- Hematopoietic cell transplantation for sickle cell disease -- Hematopoietic cell transplantation for immunodeficiency diseases -- Hematopoietic cell transplantation for osteopetrosis -- Hematopoietic cell transplantation for storage diseases -- Hematopoietic cell transplantation for macrophage and granulocyte disorders -- Hematopoietic cell transplantation for fanconi's anemia -- Mechanisms and treatment of graft failure -- Blood group incompatibilities and hemolytic complications for hematopoietic cell transplantation -- Principles of transfusion support before and after hematopoietic cell transplantation -- Vascular access and complications -- Pharmacologic prevention of acute graft-versus-host disease -- T-cell depletion to prevent graft-versus-host disease -- Manifestations and treatment of acute graft-versus-host disease -- Chronic graft-versus-host disease: clinical manifestations and therapy -- Bacterial infections -- Fungal infections after hematopoietic cell transplantation -- Cytomegalovirus infection -- Herpes simplex virus infections -- Varicella-zoster virus infection -- Epstein-Barr virus infections -- Adenoviruses, respiratory viruses, HHV-6, HHV-7, HHV-8, papovaviruses and other viruses after hematopoietic cell transplantation -- Gastrointestional and hepatic complications -- Lung injury following hematopoietic cell transplantation -- Kidney and bladder complications of hematopoietic cell transplantation -- Endocrine complications following hematopoietic cell transplantation -- Common potential drug interactions following hematopoietic cell transplantation -- Critical care of the hematopoietic cell transplant recipient -- Nutrition support of the hematopoietic cell transplant recipient -- Pain management -- Oral complications of hematopoietic cell transplantation -- Growth and development after hematopoietic cell transplantation -- Delayed nonmalignant complications after hematopoietic cell transplantation -- Secondary malignancies after hematopoietic cell transplantation -- Neurologic complications of hematopoietic cell transplantation -- Vaccination of allogeneic and autologous hematopoietic cell recipients -- Hematopoietic cell transplantation in the future. |